• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [18582 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2004     NIHR Health Technology Assessment programme Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Virtual reality exposure therapy for adults with post-traumatic stress disorder: a review of the clinical effectiveness
2020     Health Technology Wales (HTW) Virtual reality therapy for the management of procedure-related pain
1999     Comite d'Evaluation et de Diffusion des Innovations Technologiques (CEDIT) Virtual simulation in radiotherapy and 3D conformational radiation therapy
2010     NIHR Health Technology Assessment programme Virus shedding and environmental deposition of novel A (H1N1) pandemic influenza virus: interim findings
2010     NIHR Health Technology Assessment programme Virus shedding and environmental deposition of novel A(H1N1) pandemic influenza virus
2003     HAYES, Inc. Viscocanalostomy for treatment of glaucoma
2015     NIHR Health Technology Assessment programme Viscoelastic point-of-care testing to assist with the diagnosis, management and monitoring of haemostasis: a systematic review and cost-effectiveness analysis
2007     Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS) Viscosupplementation for the treatment of osteoarthritis of the knee
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Viscosupplementation for the treatment of osteoarthritis of the knee: clinical effectiveness and guidelines
2004     Agency for Healthcare Research and Quality (AHRQ) Vision rehabilitation services
2003     Institute for Clinical Systems Improvement (ICSI) Vision therapy
2011     HAYES, Inc. Vision therapy for accommodative and vergence dysfunction
2013     HAYES, Inc. Vision therapy for convergence insufficiency and accommodative dysfunction in children
2012     HAYES, Inc. Vision therapy for dyslexia and other reading and learning disabilities
2002     HAYES, Inc. Vision therapy for visual dysfunctions and dyslexia and other reading disabilities
2001     Medical Services Advisory Committee (MSAC) Visual electrodiagnosis
2006     HAYES, Inc. Visual evoked potentials for diagnosing and monitoring glaucoma
2006     HAYES, Inc. Visual evoked potentials in the diagnosis/prognosis of multiple sclerosis
2003     VA Technology Assessment Program (VATAP) Visual field testing in VA compensation and pension examinations
2009     VA Technology Assessment Program (VATAP) Visual problems in traumatic brain injury
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Visudyne
2000     Alberta Heritage Foundation for Medical Research (AHFMR) Visudyne (TM) therapy for the treatment of age-related macular degeneration
2014     HAYES, Inc. Vitagel surgical hemostat (Stryker Corporation) for perioperative hemostasis
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: an evidence-based analysis
2013     Health Quality Ontario (HQO) Vitamin B12 and cognitive function: OHTAC recommendation
2013     Health Quality Ontario (HQO) Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin B12 testing in the general population: clinical and cost-effectiveness and guidelines
2012     Malaysian Health Technology Assessment (MaHTAS) Vitamin C Injection for Cosmetic
2012     HAYES, Inc. Vitamin D and breast cancer
2009     Agency for Healthcare Research and Quality (AHRQ) Vitamin D and calcium: a systematic review of health outcomes
2014     Agency for Healthcare Research and Quality (AHRQ) Vitamin D and calcium: a systematic review of health outcomes (update)
2012     HAYES, Inc. Vitamin D supplementation and risk of fractures, falls, and bone loss
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D supplementation in long-term care residents: clinical evidence and guidelines
2012     The Regional Health Technology Assessment Centre (HTA-centrum) Vitamin D supplementation in patients with active or latent tuberculosis
2012     HAYES, Inc. Vitamin D supplementation in patients with osteoporosis
2014     NIHR Health Technology Assessment programme Vitamin D supplementation in pregnancy: a systematic review
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infection: individual patient data meta-analysis of randomised controlled trials
2019     NIHR Health Technology Assessment programme Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis
2020     Swiss Federal Office of Public Health (FOPH) Vitamin D testing
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing for northern populations: clinical and cost-effectiveness and guidelines
2015     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: a review of the clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D testing in the general population: clinical and cost-effectiveness and guidelines
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin D toxicity associated with different vitamin D dosing regimens: safety
2009     NIHR Health Technology Assessment programme Vitamin K to prevent fractures in older women: a systematic review and economic evaluation
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Vitamin supplementation for hospitalized adults: clinical evidence and guidelines
2013     Agency for Healthcare Research and Quality (AHRQ) Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2016     NIHR Health Technology Assessment programme VivaScope® 1500 and 3000 systems for detecting and monitoring skin lesions: a systematic review and economic evaluation
2009     HAYES, Inc. Vivitrol (Injectable Naltrexone) (Alkermes Inc.) for outpatient treatment of alcohol dependence
2008     HAYES, Inc. ViziLite Plus with TBlue (Zila Inc.) as an adjunct to conventional oral mucosal screening for high-risk patients
2007     Adelaide Health Technology Assessment (AHTA) VNS therapy system for the treatment of depression
2005     Adelaide Health Technology Assessment (AHTA) VNS Therapy(TM) System for the treatment of chronic or recurrent treatment-resistant depression in adults
2012     Malaysian Health Technology Assessment (MaHTAS) VNUS® Radiofrequency Ablation (RFA) for varicose vein
2014     HAYES, Inc. Vocal fold steroid injection for treatment of dysphonia
2004     Adelaide Health Technology Assessment (AHTA) Vocera (R) wireless communication
2008     NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin (LX-211) for non-infectious uveitis
2008     NIHR Horizon Scanning Centre (NIHR HSC) Voclosporin for moderate to severe plaque psoriasis
1999     Alberta Heritage Foundation for Medical Research (AHFMR) Voice controlled arthroscopic pump
2016     NIHR Horizon Scanning Centre (NIHR HSC) Voke 0.45mg inhaler for smoking cessation – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Volanesorsen - familial chylomicronemia syndrome – first line
2013     NIHR Horizon Scanning Centre (NIHR HSC) Volasertib for acute myeloid leukaemia in patients ineligible for intensive induction therapy – first line
2005     The Swedish Council on Health Technology Assessment (SBU) Volume and quality - a preliminary study
2014     HAYES, Inc. Von Hippel-Lindau (VHL) syndrome
2011     HAYES, Inc. von Willebrand Factor (VWF) gene testing for von Willebrand Disease (VWD)
2016     NIHR Horizon Scanning Centre (NIHR HSC) Vonicog alfa for severe von Willebrand disease
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for acute coronary syndrome
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorapaxar for secondary prevention of cardiovascular events
2020     The National Health Care Institute (ZIN, Zorginstituut Nederland) Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations (package advice)
2003     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Voriconazole
2008     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat (Zolinza) for cutaneous T-cell lymphoma - second line
2010     NIHR Horizon Scanning Centre (NIHR HSC) Vorinostat for refractory multiple myeloma
2015     NIHR Health Technology Assessment programme Vortioxetine for treating major depressive disorder
2012     NIHR Horizon Scanning Centre (NIHR HSC) Vosaroxin in combination with cytarabine for acute myeloid leukamaemia
2013     HAYES, Inc. VPRIV (Velaglucerase Alfa for Injection; Shire Human Genetic Therapies Inc.) for type 1 gaucher disease
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. 2: selected divisions of the departments of medicine and surgery. Supplement to report no 26 "Wait times at the MUHC 1"
2006     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. I: diagnostic imaging, joint replacement, cancer care, sight restoration, cardiac care
2007     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 3 fracture management.
2008     Technology Assessment Unit of the McGill University Health Centre (MUHC) Wait times at the MUHC. No: 4 Diagnostic imaging revisited. Adult hospitals of the MUHC.
2006     VA Technology Assessment Program (VATAP) Wait times for primary hip and knee replacement surgery
2007     Centre Hospitalier de l'Universite de Montreal(CHUM) Waiting times at CHUM 1: diagnostic imaging, hip and knee replacements,cardiac surgery, cancer care and sight restoration
2006     Danish Centre for Evaluation and Health Technology Assessment (DACEHTA) Ward rounds - a health technology assessment focused on production of knowledge
2001     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Warm-up therapy
2013     Canadian Agency for Drugs and Technologies in Health (CADTH) Warming of amniofluid: safety
2012     Canadian Agency for Drugs and Technologies in Health (CADTH) Watchful dosing of morphine or morphine equivalent dosing in the treatment of chronic non-cancer pain: a review of the clinical evidence
2009     NIHR Horizon Scanning Centre (NIHR HSC) WATCHMAN left atrial appendage (LAA) closure device for non-valvular atrial fibrillation (AF)
2013     Malaysian Health Technology Assessment (MaHTAS) Water birth
2004     Canadian Coordinating Office for Health Technology Assessment (CCOHTA) Water jet systems for surgical dissection and resection
2002     HAYES, Inc. Water-induced thermotherapy (WIT) for benign prostatic hyperplasia
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Waterless wipes for chemical eye injuries: clinical effectiveness
2006     Institute for Clinical Effectiveness and Health Policy (IECS) Wavefront analysis in refractive surgery
2015     NIHR Horizon Scanning Centre (NIHR HSC) WavSTAT4 Optical Biopsy System® for colorectal cancer diagnosis
2014     Canadian Agency for Drugs and Technologies in Health (CADTH) Wear compliance and donning/doffing of respiratory protection for bioaerosols or infectious agents: a review of the effectiveness, safety, and guidelines
2009     Adelaide Health Technology Assessment (AHTA) Wearable artificial kidney (WAK): Portable dialysis for patients with chronic kidney disease
2016     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2016     European Network for Health Technology Assessment (EUnetHTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk
2018     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk. Update 2018
2010     Blue Cross Blue Shield Association (BCBS) Wearable cardioverter-defibrillator as a bridge to implantable cardioverter-defibrillator treatment
2008     Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Web-based toolkit to facilitate European collaboration on evidence generation on promising health technologies
2001     Agencia de Evaluacion de Tecnologias Sanitarias (AETS) WEBLING project: full text web indexes that have been linguistically enhanced and supplemented by services to cross the language barrier (internal report). In cooperation with EU ESPRIT program. IPE-01/i (Internal Report)